Augmented Bone Graft Market: Global Industry Analysis and Forecast (2024-2030)
Augmented Bone Graft Market size was valued at USD 2.49 Bn. in 2023 and the total Augmented Bone Graft Market size is expected to grow at a CAGR of 6.97 % from 2024 to 2030, reaching nearly USD 3.99 Bn. by 2030.
Format : PDF | Report ID : SMR_2057
Augmented Bone Graft Market Overview
Augment bone graft is a drug/device combination product employed to rejuvenate bone by returning its regenerative abilities. The use of augment bone graft eliminates the necessity for a follow-up operation in which autologous bone being harvested thus eradicating morbidity associated with donor site. There is an increasing prominence of augmented bone graft This has been attributed to rising cases of musculoskeletal illnesses as well as the advancement in medical devices, which has seen many people opt for allograft over autograft The growth of Augmented Bone Graft market is continuously driven by factors which includes increasing advancement in technology, escalating adoption rate for new technology and others. The market however faces growth challenges due to high cost of surgeries and ethical issues associated with bone grafting procedures, notwithstanding these advancements.
One of the principal factors that is fueling the growth of the Augmented Bone Graft market is the increasing support from government bodies as well as healthcare organizations towards research and development on Augmented bone grafts. Funding as well as grants form part of the support system. Additionally, it involves facilitation in terms of regulatory approvals for advanced and new products which in turn assist in coming up with inventive solutions for bone grafts.
To get more Insights: Request Free Sample Report
Augmented Bone Graft Market Dynamics
Drivers: Increasing incidence of bone and joint disorders
One of the major factors driving the Augmented Bone Graft market expansion is the increased frequency of bone and joint illnesses, including osteoporosis, osteoarthritis, and spinal disorders. Accordingly, the market is expected to develop due to the increasing need for efficient treatment alternatives, such as bone grafts and substitutes, since these are essential for joint reconstruction, trauma operations, and spinal fusion surgeries. Additionally, the market is growing due to the growing elderly population worldwide, who are more prone to joint problems.
Rapid technological advancements in Biomaterial related to Augmented bone graft
Rising improvements in biomaterials used for bone grafting are key drivers driving Augmented Bone Graft market expansion. Accordingly, the market is expanding due to the development of artificial and biocompatible materials including calcium phosphate ceramics, bioactive glasses, and other polymers that effectively promote bone healing and regeneration. They provide a number of benefits, including a lower chance of disease transmission, reliable quality, and the capacity to modify the material's properties to meet certain clinical requirements. Furthermore, it is projected that the market would increase due to the extensive adoption of cutting-edge technologies like three-dimensional (3D) printing, which make it possible to create personalized grafts that precisely match the anatomy of the patient while also enhancing surgical outcomes.
Challenges: High cost of Implantation
Even though bone grafting techniques can be minimally intrusive in certain situations, they still come with surgical expenditures that include anesthesia, hospital or clinic fees, and surgeon fees. bone grafting procedures can be costly, particularly when combined with other medical procedures like implant placement. Many people find that paying for these procedures is too costly, some patients find these combined expenses to be a barrier, which could hinder the market's growth.
Augmented Bone Graft Market Segment Analysis:
Based on Type, Augmented market is divided into Synthetic Bone Graft Xenograft Allograft Autograft Alloplast Demineralized Allograft Others. Synthetic bone grafts are a vital segment of the growing Augmented bone graft market. They offer a readily available, safe, and versatile alternative to traditional bone graft options. As technology advances and costs decrease, synthetic bone grafts are expected to play an increasingly prominent role in bone reconstruction and implant placement procedures. which is expected to drive the segment growth.
Augmented Bone Graft Market Regional Insights:
Due to bone-related disorders being highly common, as well as advanced health care infrastructure and presence of key market players in the region, North America has the largest market share. Consequently, the market growth is boosted by the rising demand for bone grafts and substitutes for orthopedic procedures such as spinal fusion and joint reconstruction surgeries. The North American augmented bone graft market is showing strong growth because bone disorders are increasing and surgical techniques are getting better.
The United States does extensive research activities and has a well-established health care infrastructure. As investments in healthcare rise and people learn more about bone graft procedures, Canada also shows positive growth of the Augmented bone graft market because of growing incidence of osteoporosis and arthritis, the growing number of knee and hip replacement procedures, and technological advancements in bone graft materials are driving the market expansion. Mexico also contributing to the growth of the market due to rising incident of bone related disorder and technological Advancement fueling the growth of Augmented Bone Graft market.
Augmented Bone Graft Market Competitive Landscape
- In July 2023, Cerapedics Inc. announced that it has expanded its headquarters in the Denver metro area to support the growth of its products, which include the FDA-approved i-FACTOR bone graft for cervical spinal fusion and a next-generation product that is currently being evaluated for lumbar spinal fusion.
- In February 2023, NuVasive, Inc. announced that its Modulus Cervical interbody implant was approved by FDA, expanding its C360 product portfolio.
- In January 2022, Johnson & Johnson partnered with Microsoft Corporation, Inc. The Johnson &Johnson Medical Devices Companies (JJMDC) collaborated with Microsoft Corporation Inc, (US) to enable and expand JJMDC’s secure and compliant digital surgery ecosystem.
Augmented Bone Graft Market Scope
Augmented Bone Graft Market |
|
Market Size in 2023 |
USD 2.49 Bn. |
Market Size in 2030 |
USD 3.99 Bn. |
CAGR (2024-2030) |
6.97 % |
Historic Data |
2018-2022 |
Base Year |
2023 |
Forecast Period |
2024-2030 |
Segments |
By Type
|
By Application
|
|
By End User
|
|
Regional Scope |
North America- United States, Canada, and Mexico Europe – United Kingdom, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America |
Augmented Bone Graft Market Key Players
- Zimmer Biomet
- DePuy Synthes
- Stryker Corporation
- NuVasive Inc.
- Arthrex Inc.
- Integra LifeSciences
- Baxter International Inc.
- Musculoskeletal Transplant Foundation
- XTANT MEDICAL
- SeaSpine
- LifeNet Health
- Smith & Nephew
- NovaBone Products Pvt. Ltd.
- Exactech, Inc
- RTI Surgical
- Orthofix Medical Inc
- Envista holdings corporation
- Wiltrom Co
- Green Bone
- XX Ltd
Frequently Asked Questions
High cost of material and stringent regulations is the restrain of Augmented Bone Graft Market.
Augmented Bone Graft Market size was valued at USD 2.49 Billion in 2023 and the total Augmented Bone Graft Market size is expected to grow at a CAGR of 6.97 % from 2024 to 2030, reaching nearly USD 3.99 Billion by 2030.
Segments are covered based on By Type, By Application, By End User.
1. Research Methodology
1.1 Research Data
1.1.1. Primary Data
1.1.2. Secondary Data
1.2. Market Size Estimation
1.2.1. Bottom-Up Approach
1.2.2. Top-Down Approach
1.3. Market Breakdown and Data Triangulation
1.4. Research Assumption
2. Augmented Bone Graft Market: Executive Summary
2.1. Market Overview
2.2. Market Size (2023) and Forecast (2024 – 2030) and Y-O-Y%
2.3. Market Size (USD) and Market Share (%) – By Segments and Regions
3. Global Augmented Bone Graft Market: Competitive Landscape
3.1. SMR Competition Matrix
3.2. Key Players Benchmarking
3.2.1. Company Name
3.2.2. Headquarter
3.2.3. Product Segment
3.2.4. End-user Segment
3.2.5. Y-O-Y%
3.2.6. Revenue (2023)
3.2.7. Profit Margin
3.2.8. Market Share
3.2.9. Company Locations
3.3. Market Structure
3.3.1. Market Leaders
3.3.2. Market Followers
3.3.3. Emerging Players
3.4. Consolidation of the Market
3.4.1. Strategic Initiatives and Developments
3.4.2. Mergers and Acquisitions
3.4.3. Collaborations and Partnerships
3.4.4. Product Launches and Innovations
4. Augmented Bone Graft Market: Dynamics
4.1. Augmented Bone Graft Market Trends by Region
4.1.1. North America
4.1.2. Europe
4.1.3. Asia Pacific
4.1.4. Middle East and Africa
4.1.5. South America
4.2. Augmented Bone Graft Market Drivers
4.3. Augmented Bone Graft Market Restraints
4.4. Augmented Bone Graft Market Opportunities
4.5. Augmented Bone Graft Market Challenges
4.6. PORTER’s Five Forces Analysis
4.6.1. Intensity of the Rivalry
4.6.2. Threat of New Entrants
4.6.3. Bargaining Power of Suppliers
4.6.4. Bargaining Power of Buyers
4.6.5. Threat of Substitutes
4.7. PESTLE Analysis
4.7.1. Political Factors
4.7.2. Economic Factors
4.7.3. Social Factors
4.7.4. Technological Factor
4.7.5. Legal Factors
4.7.6. Environmental Factors
4.8. Technological Roadmap
4.9. Regulatory Landscape by Region
4.9.1. North America
4.9.2. Europe
4.9.3. Asia Pacific
4.9.4. Middle East and Africa
4.9.5. South America
5. Augmented Bone Graft Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
5.1. Augmented Bone Graft Market Size and Forecast, by Type (2023-2030)
5.1.1. Synthetic Bone Graft
5.1.2. Xenograft
5.1.3. Allograft
5.1.4. Autograft
5.1.5. Alloplast
5.1.6. Deminerlized Allograft
5.1.7. Others
5.2. Augmented Bone Graft Market Size and Forecast, by Application (2023-2030)
5.2.1. Spinal fusion
5.2.2. Dental
5.2.3. Joint reconstruction
5.2.4. Foot & ankle
5.2.5. Craniomaxillofacial
5.2.6. Long bone
5.3. Augmented Bone Graft Market Size and Forecast, by End User (2023-2030)
5.3.1. Hospitals
5.3.2. Dental Clinics
5.3.3. Others (Ortho Clinics, Research)
5.4. Augmented Bone Graft Market Size and Forecast, by Region (2023-2030)
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Middle East and Africa
5.4.5. South America
6. North America Augmented Bone Graft Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
6.1. North America Augmented Bone Graft Market Size and Forecast, by Type (2023-2030)
6.1.1. Synthetic Bone Graft
6.1.2. Xenograft
6.1.3. Allograft
6.1.4. Autograft
6.1.5. Alloplast
6.1.6. Deminerlized Allograft
6.1.7. Others
6.2. North America Augmented Bone Graft Market Size and Forecast, by Application (2023-2030)
6.2.1. Spinal fusion
6.2.2. Dental
6.2.3. Joint reconstruction
6.2.4. Foot & ankle
6.2.5. Craniomaxillofacial
6.2.6. Long bone
6.3. North America Augmented Bone Graft Market Size and Forecast, by End User (2023-2030)
6.3.1. Hospitals
6.3.2. Dental Clinics
6.3.3. Others (Ortho Clinics, Research)
6.4. North America Augmented Bone Graft Market Size and Forecast, by Country (2023-2030)
6.4.1. United States
6.4.2. Canada
6.4.3. Mexico
7. Europe Augmented Bone Graft Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
7.1. Europe Augmented Bone Graft Market Size and Forecast, by Type (2023-2030)
7.2. Europe Augmented Bone Graft Market Size and Forecast, by Application (2023-2030)
7.3. Europe Augmented Bone Graft Market Size and Forecast, by End User (2023-2030)
7.4. Europe Augmented Bone Graft Market Size and Forecast, by Country (2023-2030)
7.4.1. United Kingdom
7.4.2. France
7.4.3. Germany
7.4.4. Italy
7.4.5. Spain
7.4.6. Sweden
7.4.7. Russia
7.4.8. Rest of Europe
8. Asia Pacific Augmented Bone Graft Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
8.1. Asia Pacific Augmented Bone Graft Market Size and Forecast, by Type (2023-2030)
8.2. Asia Pacific Augmented Bone Graft Market Size and Forecast, by Application (2023-2030)
8.3. Asia Pacific Augmented Bone Graft Market Size and Forecast, by End User (2023-2030)
8.4. Asia Pacific Augmented Bone Graft Market Size and Forecast, by Country (2023-2030)
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. South Korea
8.4.5. Australia
8.4.6. ASEAN
8.4.7. Rest of Asia Pacific
9. Middle East and Africa Augmented Bone Graft Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
9.1. Middle East and Africa Augmented Bone Graft Market Size and Forecast, by Type (2023-2030)
9.2. Middle East and Africa Augmented Bone Graft Market Size and Forecast, by Application (2023-2030)
9.3. Middle East and Africa Augmented Bone Graft Market Size and Forecast, by End User (2023-2030)
9.4. Middle East and Africa Augmented Bone Graft Market Size and Forecast, by Country (2023-2030)
9.4.1. South Africa
9.4.2. GCC
9.4.3. Egypt
9.4.4. Rest of the Middle East and Africa
10. South America Augmented Bone Graft Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030)
10.1. South America Augmented Bone Graft Market Size and Forecast, by Type (2023-2030)
10.2. South America Augmented Bone Graft Market Size and Forecast, by Application (2023-2030)
10.3. South America Augmented Bone Graft Market Size and Forecast, by End User (2023-2030)
10.4. South America Augmented Bone Graft Market Size and Forecast, by Country (2023-2030)
10.4.1. Brazil
10.4.2. Argentina
10.4.3. Rest Of South America
11. Company Profile: Key Players
11.1. Zimmer Biomet
11.1.1. Company Overview
11.1.2. Business Portfolio
11.1.3. Financial Overview
11.1.3.1. Total Revenue
11.1.3.2. Segment Revenue
11.1.3.3. Regional Revenue
11.1.4. SWOT Analysis
11.1.5. Strategic Analysis
11.1.6. Recent Developments
11.2. DePuy Synthes
11.3. Stryker Corporation
11.4. NuVasive Inc.
11.5. Arthrex Inc.
11.6. Integra LifeSciences
11.7. Baxter International Inc.
11.8. Musculoskeletal Transplant Foundation
11.9. XTANT MEDICAL
11.10. SeaSpine
11.11. LifeNet Health
11.12. Smith & Nephew
11.13. NovaBone Products Pvt. Ltd.
11.14. Exactech, Inc
11.15. RTI Surgical
11.16. Orthofix Medical Inc
11.17. Envista holdings corporation
11.18. Wiltrom Co
11.19. Green Bone
11.20. XX Ltd
12. Key Findings
13. Analyst Recommendations
13.1. Strategic Recommendations
13.2. Future Outlook